InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
50%
T+90 mean return
-5.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Andrews Julie, Director. Director active across 2 companies, notably RxSight, Inc.. Cumulatively, 10 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €724k. Activity tracked since 3 August 2021. The latest transaction was disclosed on 3 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
37,037 sharesCommon StockSEC:0001193125-26-275819:0
34,600 shares0Common StockSEC:0000950170-25-033602:0
4,655 shares@ US$17.8916.4% of flowCommon StockSEC:0000950170-25-007228:0
11,940 shares@ US$57.8399100.0% of flowCommon StockSEC:0000950170-24-074473:0
2,554 sharesCommon StockSEC:0000950170-24-071281:0
32,967 shares@ US$13.6583.6% of flowCommon StockSEC:0001209191-24-001811:0
5,731 shares0Common StockSEC:0001209191-23-034296:0
8,624 shares0Common StockSEC:0001209191-22-034386:0
5,733 shares0Common StockSEC:0000899243-21-031812:0
5,733 shares0Common StockSEC:0000899243-21-031812
10 of 10 declarations
About Andrews Julie
Julie Andrews is a Director at RxSight, Inc. She brings her expertise in strategy and governance to the board. As a board member, Julie Andrews participates in strategic decision-making and overseeing the company's performance. Her experience in the healthcare sector is a valuable asset for RxSight.
